1.
Lasers Med Sci
; 39(1): 237, 2024 Sep 20.
Artículo
en Inglés
| MEDLINE
| ID: mdl-39302494
2.
Lasers Med Sci
; 39(1): 105, 2024 Apr 17.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38630151
3.
Oxf Med Case Reports
; 2018(12): omy105, 2018 Dec.
Artículo
en Inglés
| MEDLINE
| ID: mdl-30487990
RESUMEN
Cabozantinib is a tyrosine kinase inhibitor which is increasingly being used for the treatment of metastatic renal cell cancer. Skin toxicity such as palmar-plantar erythrodysesthesia is not uncommon with such agents. However, bullous skin reactions are not common and we report the case of a patient with metastatic renal cell cancer who experienced such cutaneous toxicity.